These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34350277)
1. International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives. Marthin JK; Lucas JS; Boon M; Casaulta C; Crowley S; Destouches DMS; Eber E; Escribano A; Haarman E; Hogg C; Maitre B; Marsh G; Martinu V; Moreno-Galdó A; Mussaffi H; Omran H; Pohunek P; Rindlisbacher B; Robinson P; Snijders D; Walker WT; Yiallouros P; Johansen HK; Nielsen KG ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34350277 [TBL] [Abstract][Full Text] [Related]
2. Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses. Alanin MC Dan Med J; 2017 May; 64(5):. PubMed ID: 28552099 [TBL] [Abstract][Full Text] [Related]
3. International consensus guideline for reporting transmission electron microscopy results in the diagnosis of primary ciliary dyskinesia (BEAT PCD TEM Criteria). Shoemark A; Boon M; Brochhausen C; Bukowy-Bieryllo Z; De Santi MM; Goggin P; Griffin P; Hegele RG; Hirst RA; Leigh MW; Lupton A; MacKenney K; Omran H; Pache JC; Pinto A; Reinholt FP; Schroeder J; Yiallouros P; Escudier E; Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32060067 [TBL] [Abstract][Full Text] [Related]
4. Proceedings of the 3rd BEAT-PCD Conference and 4th PCD Training School. Farley H; Rubbo B; Bukowy-Bieryllo Z; Fassad M; Goutaki M; Harman K; Hogg C; Kuehni CE; Lopes S; Nielsen KG; Norris DP; Reula A; Rumman N; Shoemark A; Wilkins H; Wisse A; Lucas JS; Marthin JK BMC Proc; 2018; 12(Suppl 16):64. PubMed ID: 30807620 [TBL] [Abstract][Full Text] [Related]
7. Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school: part 1. Halbeisen F; Hogg C; Alanin MC; Bukowy-Bieryllo Z; Dasi F; Duncan J; Friend A; Goutaki M; Jackson C; Keenan V; Harris A; Hirst RA; Latzin P; Marsh G; Nielsen K; Norris D; Pellicer D; Reula A; Rubbo B; Rumman N; Shoemark A; Walker WT; Kuehni CE; Lucas JS BMC Proc; 2018; 12(Suppl 2):1. PubMed ID: 29630684 [TBL] [Abstract][Full Text] [Related]
8. Proceedings of the COST action BM1407 inaugural conference BEAT-PCD: translational research in primary ciliary dyskinesia - bench, bedside, and population perspectives. Rubbo B; Behan L; Dehlink E; Goutaki M; Hogg C; Kouis P; Kuehni CE; Latzin P; Nielsen K; Norris D; Nyilas S; Price M; Lucas JS; BMC Proc; 2016; 10(Suppl 9):66. PubMed ID: 28813544 [TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia. Alanin MC; Nielsen KG; von Buchwald C; Skov M; Aanaes K; Høiby N; Johansen HK Clin Microbiol Infect; 2015 Dec; 21(12):1093.e1-7. PubMed ID: 26341913 [TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
11. Study protocol: the ear-nose-throat (ENT) prospective international cohort of patients with primary ciliary dyskinesia (EPIC-PCD). Goutaki M; Lam YT; Alexandru M; Anagiotos A; Armengot M; Bequignon E; Boon M; Burgess A; Coste A; Emiralioglu N; Erdem E; Haarman EG; Harris A; Hool SL; Karadag B; Kim S; Latzin P; Lorent N; Ozcelik U; Reula A; Roehmel J; van Gogh C; Yiallouros P; Zappe SM; ; Papon JF BMJ Open; 2021 Oct; 11(10):e051433. PubMed ID: 34635525 [TBL] [Abstract][Full Text] [Related]
12. Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis. Contarini M; Shoemark A; Rademacher J; Finch S; Gramegna A; Gaffuri M; Roncoroni L; Seia M; Ringshausen FC; Welte T; Blasi F; Aliberti S; Chalmers JD Multidiscip Respir Med; 2018; 13(Suppl 1):26. PubMed ID: 30151188 [TBL] [Abstract][Full Text] [Related]
18. Variations in infection control practices suggest a need for guidelines in primary ciliary dyskinesia patient care. Caliskan AB; Horani A; Manion M; Brody SL Pediatr Pulmonol; 2022 Apr; 57(4):1072-1075. PubMed ID: 35043594 [TBL] [Abstract][Full Text] [Related]
19. Nasal nitric oxide and pulmonary radioaerosol mucociliary clearance as supplementary tools in diagnosis of primary ciliary dyskinesia. Marthin JK Dan Med Bull; 2010 Aug; 57(8):B4174. PubMed ID: 20682136 [TBL] [Abstract][Full Text] [Related]
20. Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia. Kobbernagel HE; Buchvald FF; Haarman EG; Casaulta C; Collins SA; Hogg C; Kuehni CE; Lucas JS; Omran H; Quittner AL; Werner C; Nielsen KG BMC Pulm Med; 2016 Jul; 16(1):104. PubMed ID: 27450411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]